Philips partners with Middle East Healthcare Company to launch state-of-the-art sleep disorder management services in Saudi Arabia through Saudi German Health Group

The partnership is aimed at providing innovative solutions to patients suffering from acute disorders such as Obstructive Sleep Apnea

  
Philips partners with Middle East Healthcare Company to launch state-of-the-art sleep disorder management services in Saudi Arabia through Saudi German Health Group

Jeddah, Saudi Arabia –  Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Saudi German Hospital Group, one of the key healthcare providers in the Middle East & Africa, covering a wide geography, signed a three-year agreement to establish a state of the art Sleep Disorders Management service. The partnership is aimed at providing innovative solutions to patients suffering from acute disorders such as Obstructive Sleep Apnea (OSA).

With the help of this partnership, Philips will be able to offer patients of Saudi German Health easy access to the latest technologies to manage sleep difficulties through an integrated, diagnostic and therapeutic program that covers the patients’ entire treatment cycle. It will also further enable a thorough follow-up procedure to ensure that patients comply to the recommended treatment, health guidelines and experience the expected improvement.

Importance of sleep disorder management in Saudi Arabia

OSA is a highly prevalent as well as an under-diagnosed disease worldwide. With the advent of a global pandemic causing personal and professional strain on the lives of Saudi citizens and residents, study in KSA suggest that one out of ten adult middle-aged men carry a high risk of OSA[1]. With such a strong need to cater to the sleep disorders in the region, this partnership will help to manage the conditions of the patients, improve their quality of life, and reduce the risk of developing serious health issues.

Philips has a proven track record in sleep disorders related to OSA and provides highly advanced treatment technologies ensuring complete care.

On the occasion of signing this agreement, Eng. Mohamed Sindi, CEO of Philips Healthcare Saudi Arabia said: “The cumulative long-term effects of sleep loss and sleep disorders have been associated with a wide range of deleterious health consequences including an increased risk of hypertension, diabetes, obesity, depression, heart attack, and stroke. Our strategic partnership with Middle East Healthcare Company for sleep disorder management services will bring state of the art Philips solutions to the KSA region and improve the overall quality of the patients leading to better lives.”

Dr. Makarem Batterjee, President of Middle East Healthcare Company (MEAHCO), said: “Sleep Disorders Management is an important professional service that we look forward to making it available to our community. Signing this project with Philips is in line with our strategic relation that we are confident will expand in deferent directions across Saudi German Health Group.”

Philips Sleep Lab

Through this agreement, Philips will provide number of sleep disorder centers within Saudi German Health Hospitals in KSA. Patients spend a night in the Sleep Center to ensure careful observation of their sleep pattern. Philips cutting-edge technology helps to diagnose several sleep disorders, where patients with positive Obstructive Sleep Apnea (OSA) will benefit from Philips Positive Airway Therapy devices that help managing OSA.

The partnership aims to build a treatment journey starting from education for the patients on their condition, diagnostics of OSA, providing treatment solutions and following up with the patients to increase treatment compliance. It will also create more awareness about sleep disorders amongst the health care professionals, institutions, medical schools, governmental health care providers and the public of KSA.

[1] Prevalence and risk factors of obstructive sleep apnea syndrome in a Saudi Arabian population https://pubmed.ncbi.nlm.nih.gov/28469718/ 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.


More From Press Releases